Visit CURE at http://curenet.org and CURE BioScience Explorations at http://bioscienceexplorations.org

July 2010
 

Home
CURE's Annual Meeting and BioHaven Series Showcase Connecticut Biopharma
Yale Cell Biology Researcher Wins $1 Million Prize
Healthcare Reform Focus of CURE Annual Meeting
Ion Torrent & 4 Biotechs Draw Venture Capital
JS Genetics Presents at CURE/Yale BioHaven Series
Amarin Corporation Focus of CURE/Yale BioHaven Presentation
Jonathan Rothberg Presents at CURE Yale BioHaven
CT Stem Cell Research Roundup
CURE Member News Digest

Jonathan Rothberg Presents at CURE/Yale BioHaven
 


Paul Pescatello of CURE


Dr. Jonathan Rothberg


Networking afterwards

    

In his introduction of Dr. Jonathan Rothberg, the speaker at the CURE/Yale BioHaven Entrepreneurship seminar March 31, CURE president Paul Pescatello described Dr.  Rothberg as a "serial entrepreneur" who has been called the father of high-speed (massively parallel) DNA sequencing.

Dr. Rothberg is the founder of Ion Torrent Systems of Guilford, CT. The company has developed a DNA sequencing system that directly translates chemical signals into digital information on a semiconductor chip.

Ion Torrent launched the Ion Personal Genome Machine in 2010. The Ion Personal Genome Machine (PGM™) sequencer can do a run in about an hour, offers semiconductor scalability and is one tenth the price of other sequencers to buy and to run, the company says.

Dr. Rothberg is also co-founder and chairman of RainDance Technologies, which provides research tools based on microdroplet technology.

Earlier he founded 454 Life Sciences of Branford, now a Roche company, which develops systems for ultra-high-throughput DNA sequencing; and before that CuraGen, formerly of Branford and recently acquired by Celldex, which developed treatments for cancer.


He is also the founder of ClariFI Corporation, a provider of financial software and services focused on quantitative portfolio management and research.

He founded The Rothberg Institute for Childhood Diseases in Guilford, a non-profit organization dedicated to finding a cure for children suffering from Tuberous Sclerosis Complex.

Dr. Rothberg was on teams that completed the first sequencing of an individual human genome (that of bioscientist James D. Watson), initiated sequencing of the Neanderthal genome, and cracked the mystery behind the disappearance of the honey bee. 

Born in 1963 in New Haven, Dr. Rothberg earned a B.S. in chemical engineering with an option in biomedical engineering from Carnegie Mellon University and an M.S., M.Phil, and Ph.D. in biology from Yale University.
 
 
Copyright 2010 © Connecticut United for Research Excellence. All rights reserved. Visit CURE at http://curenet.org and CURE BioScience Explorations at http://bioscienceexplorations.org
Click here for Archive of back issues.
Newsletter developed and edited by HarveyMalis Communications LLC, Guilford, Conn.

Managing Your Subscriptions
Click on the "Manage your subscription" link below and then on "Edit Your Profile." To subscribe to a publication, type a "y" in the box to the right of the publication name. To unsubscribe, leave the box blank.